DMT-dI-CE-Phosphoramidite
DMT-dI-CE-Phosphoramidite - N (Normal) / 0.25g / 30mL screwed bottle-28 is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Details
Details
DMT-dI-CE-Phosphoramidite is a DNA phosphoramidite monomer used for solid-phase oligonucleotide synthesis.
It contains a deoxyinosine (dI), a 5’-dimethoxytrityl (DMT) protecting group for 5’-hydroxyl protection, and a cyanoethyl (CE) protecting group on phosphite.
dI serves as a universal base that can pair with dA, dC, or dT in DNA duplexes through wobble base-pairing.
Applications
Degenerate and universal primers
Wobble base-pairing of dI makes it particularly valuable in the design of degenerate PCR or sequencing primers.[3]
Mixed or ambiguous sequence probes
Useful in probe design for hybridization assays, mutation detection, and SNP screening where base variability must be tolerated without fully compromising binding efficiency.[4]
Features and Benefits
Other Notes
- Diluent: Anhydrous Acetonitrile.
- Storage: Store in a dry and inert atmosphere at -20 °C.
- Coupling: 6 minute coupling time recommended.
- Oxidation: 3 minute coupling time (inosine is susceptible to damage by iodine).
Reference
Specifications
Specifications
-
Catalog No.PD6-002PD6-002PD6-002PD6-002PD6-002PD6-002PD6-002PD6-002
-
CAS No.141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7
-
SMILESO=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1
-
Molecular FormulaC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7P
-
Molecular Weight754.55754.55754.55754.55754.55754.55754.55754.55
-
AppearanceWhite powderWhite powderWhite powderWhite powderWhite powderWhite powderWhite powderWhite powder
-
PurityHPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%
-
Storage Condition-20℃-20℃-20℃-20℃-20℃-20℃-20℃-20℃
-
Moisture ContentK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/w
Documentation
Documentation
DMT-dI-CE-Phosphoramidite is a DNA phosphoramidite monomer used for solid-phase oligonucleotide synthesis.
It contains a deoxyinosine (dI), a 5’-dimethoxytrityl (DMT) protecting group for 5’-hydroxyl protection, and a cyanoethyl (CE) protecting group on phosphite.
dI serves as a universal base that can pair with dA, dC, or dT in DNA duplexes through wobble base-pairing.
Applications
Degenerate and universal primers
Wobble base-pairing of dI makes it particularly valuable in the design of degenerate PCR or sequencing primers.[3]
Mixed or ambiguous sequence probes
Useful in probe design for hybridization assays, mutation detection, and SNP screening where base variability must be tolerated without fully compromising binding efficiency.[4]
Features and Benefits
Other Notes
- Diluent: Anhydrous Acetonitrile.
- Storage: Store in a dry and inert atmosphere at -20 °C.
- Coupling: 6 minute coupling time recommended.
- Oxidation: 3 minute coupling time (inosine is susceptible to damage by iodine).
Reference
-
Catalog No.PD6-002PD6-002PD6-002PD6-002PD6-002PD6-002PD6-002PD6-002
-
CAS No.141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7141684-35-7
-
SMILESO=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1O=C1C2=C(N([C@H]3C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1
-
Molecular FormulaC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7PC40H47N6O7P
-
Molecular Weight754.55754.55754.55754.55754.55754.55754.55754.55
-
AppearanceWhite powderWhite powderWhite powderWhite powderWhite powderWhite powderWhite powderWhite powder
-
PurityHPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%
-
Storage Condition-20℃-20℃-20℃-20℃-20℃-20℃-20℃-20℃
-
Moisture ContentK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/w
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
